載入...
Targeting GM-CSF in COVID-19 Pneumonia: Rationale and Strategies
COVID-19 is a clinical syndrome ranging from mild symptoms to severe pneumonia that often leads to respiratory failure, need for mechanical ventilation, and death. Most of the lung damage is driven by a surge in inflammatory cytokines [interleukin-6, interferon-γ, and granulocyte-monocyte stimulatin...
Na minha lista:
發表在: | Front Immunol |
---|---|
Main Authors: | , , , , , , , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
Frontiers Media S.A.
2020
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7348297/ https://ncbi.nlm.nih.gov/pubmed/32719685 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.01625 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|